23 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
survive.
17. DISPUTE RESOLUTION
Disputes. Adaptimmune and Noile-Immune recognize that a dispute, controversy or claim of any nature whatsoever arising … this Agreement, the JSC shall, in particular:
work to resolve, through good faith discussions, any dispute, controversy or claim between the Parties
10-K
2016 FY
EX-10.19
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
express provision to the contrary, Executive and the Company agree that any claim, controversy or dispute between Executive and the Company (including
10-K
2016 FY
EX-10.18
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
. Agreement to Arbitrate.
(a) Notwithstanding any express provision to the contrary, Executive and the Company agree that any claim, controversy
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
that any claim, controversy or dispute between Employee and the Company (including without limitation the Company’s affiliates, officers, executives
8-K
EX-10.1
h124zfo2c
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
fexujn
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
10-K
EX-10.20
p3xxya3 cbmeq2rsz09w
13 Mar 17
Annual report
12:00am
8-K
EX-10.01
um1yv9t aa
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
1xm295dtqv9sz0
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
w2vkoed0a02
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
10-K
EX-10.16
efvizws yqk3
13 Mar 17
Annual report
12:00am
8-K
EX-1.1
p5iju0
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
pn9p2wuf6ds3k zlsv
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
S-3ASR
EX-1.2
ppeqeqs
10 Aug 20
Automatic shelf registration
5:01pm